research database

Search results

Found 10 projects for which the description matched your query. Click on project ID for more detail on the project.

IDDescription
139Membership Survey, Lancaster
141Convict transportation, links with Lancaster by U3A Local Research Group
140Naval vessels named HMS Lancaster 1694-1900 by U3A Local Research Group
142Transcribing early Port of Lancaster documents & account books by U3A Local Research Group
477Lancaster and Morecambe's Architecture Group experienced the practical problems of designing a building by researching the issues of a (fictional) new library which had to be located in a vacated shop.
643Stem Cell Research This is a brief overview of “the State of the Art” regarding stem cells and their role in medicine in the 21st century, introducing what stem cells are and where they originate. Stem cell classification covers totipotent, pluripotent and multiple potent stem cells and their origins. What adult and embryonic stem cells including cord blood cells can provide to medicine is covered and the stem cell bank and some of the diseases potentially helped by treatment with stem cells is discussed. The talk includes the challenges posed by an ageing population and the use of stem cells in diseases that are becoming more prevalent, as the life expectancy of individuals increases, e.g. Parkinson’s disease with all its associated morbidity. Where research is likely to develop next for stem cells concludes the presentation.
730Multi-modal study regarding the value of non-pharmacological intervention in Alzheimer's
731Defying Dementia
732Eye tracking as an early indicator of Alzheimer's
800This presentation explains what a genome is and introduces the 100,000 Human Genome project. Chromosome abnormalities and genetic defects will be discussed and the way that modern medicine is starting to tackle these issues shown. The ethical, social and legal implications of these new technologies will be raised. Issues include 3 parent babies, designer babies, eugenics, possible eradication of disease, personalised, targeted treatments and the technique CRISP-R which uses “genetic scissors” to edit genes.